Compare FLO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLO | ETON |
|---|---|---|
| Founded | 1919 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2000 | 2018 |
| Metric | FLO | ETON |
|---|---|---|
| Price | $6.17 | $59.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $11.20 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 6.5M | 636.1K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | ★ 11.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.39 | ★ 0.41 |
| Revenue | ★ $5,256,479,000.00 | $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $0.65 | $47.23 |
| P/E Ratio | ★ $16.21 | $144.74 |
| Revenue Growth | 3.00 | ★ 104.94 |
| 52 Week Low | $6.10 | $14.27 |
| 52 Week High | $14.41 | $66.37 |
| Indicator | FLO | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 27.88 | 57.85 |
| Support Level | N/A | $15.66 |
| Resistance Level | $8.86 | $66.37 |
| Average True Range (ATR) | 0.30 | 2.83 |
| MACD | -0.08 | -0.94 |
| Stochastic Oscillator | 5.94 | 29.82 |
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.